Noriko Yamane
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Noriko Yamane has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Ken-Ichi Kumagai
Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sakuradai 18-1, Sagamihara, Kanagawa 228-8522, Japan
1 shared publication - Konagi Tanaka
Clinical Research Center, National Hospital Organization Sagamihara Hospital, Sakuradai 18-1, Minami-ku, Kanagawa 252-0315, Japan
1 shared publication - Naoshi Fukui
National Hospital Organization Sagamihara Hospital, Sagamihara, Japan
1 shared publication - Noriyuki Shiobara
Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sakuradai 18-1, Sagamihara, Kanagawa 228-8522, Japan
1 shared publication - Riako Masuda
Clinical Research Center, National Hospital Organization Sagamihara Hospital, Sakuradai 18-1, Minami-ku, Kanagawa 252-0315, Japan
1 shared publication - Ryuji Suzuki
Department of Rheumatology and Clinical Immunology, Clinical Research Center for Rheumatology and Allergy, Sagamihara National Hospital, National Hospital Organization, 18-1 Sakuradai, Minami-ku, Sagamihara 252-0392, Japan
1 shared publication
Latest Publications
- Open Access
- 1 January 2008
- Published by Springer Nature in Journal of Inflammation
- Vol. 5 (1) , 5
Proinflammatory role of amphiregulin, an epidermal growth factor family member whose expression is augmented in rheumatoid arthritis patients
The epidermal growth factor (EGF) and EGF receptor (EGFR) families play important roles in the hyperplastic growth of several tissues as well as tumor growth. Since synovial hyperplasia in rheumatoid arthritis (RA) resembles a tumor, involvement of the EGF/EGFR families in RA pathology has been implied. Although several reports have suggested that ErbB2 is the most important member of the EGFR family for the synovitis in RA, it remains unclear which members of the EGF family are involved. To clarify the EGF-like growth factors involved in the pathology of RA, we investigated the expression levels of seven major EGF-like growth factors in RA patients compared with those in osteoarthritis (OA) patients and healthy control subjects.
- 1 January 2008
- Published by Springer Nature in Journal of Inflammation
- Vol. 5 (1) , 5
Open AccessProinflammatory role of amphiregulin, an epidermal growth factor family member whose expression is augmented in rheumatoid arthritis patients
The epidermal growth factor (EGF) and EGF receptor (EGFR) families play important roles in the hyperplastic growth of several tissues as well as tumor growth. Since synovial hyperplasia in rheumatoid arthritis (RA) resembles a tumor, involvement of the EGF/EGFR families in RA pathology has been implied. Although several reports have suggested that ErbB2 is the most important member of the EGFR family for the synovitis in RA, it remains unclear which members of the EGF family are involved. To clarify the EGF-like growth factors involved in the pathology of RA, we investigated the expression levels of seven major EGF-like growth factors in RA patients compared with those in osteoarthritis (OA) patients and healthy control subjects.